Vaccine News and Research

Latest Vaccine News and Research

Tetanus protection requires booster shots every 10 years, starting in adolescence

As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.

29 Jul 2004

New process that simplifies the production of proteins

F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.

29 Jul 2004

Eradicating deadly E. coli O157:H7 from the bottoms of cows may prevent future outbreaks of food poisoning

According to an article in the August 2004 issue Microbiology Today, the quarterly magazine of the Society for General Microbiology, the majority of people with E. coli O157:H7, picked up the infection from cattle, either through direct contact with faeces or by consuming contaminated meat or milk.

28 Jul 2004

Research using genomic testing reveals new information on flesh-eating bacteria

New research using nearly a dozen different genomic testing procedures has revealed unprecedented detail about the molecular characteristics and virulence of group A streptococcus (GAS), the “flesh-eating” bacteria, according to scientists at the Rocky Mountain Laboratories, part of the National Institute of Allergy and Infectious Diseases.

27 Jul 2004

California's first human death from West Nile virus (WNV)

West Nile virus (WNV) has claimed the life of a 57-year old Orange County man, making him the first to die in California from the virus, Dr. Richard Joseph Jackson, state public health officer, announced today.

26 Jul 2004

How ulcer bugs stick to stomach

Scientists working to develop a vaccine for the bacterium Helicobacter pylori, the primary cause of ulcers and a contributor to stomach cancers, have uncovered new intricacies in the way the bacterium sticks to the lining of the human stomach.

26 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

Autism antibodies are not genetically determined, as parents do not exhibit them

Autism produces a widespread range of antibodies that act against brain tissue and one protein in particular seems to be the major target of these antibodies claim a group of scientists in the July issue of the Journal of Neuroimmunology.

23 Jul 2004

Computer modeling method for mapping the evolution of the influenza virus

A University of California scientist working at Los Alamos National Laboratory with collaborators from the University of Cambridge (England) and the World Health Organization National Influenza Center at Erasmus Medical Center, (Rotterdam, Netherlands) have developed a computer modeling method for mapping the evolution of the influenza virus.

21 Jul 2004

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

World's first personal facemask for SARS protection

Triosyn Corp., a developer of products aimed at protecting against microbial threats, announced today that tests conducted by Health Canada’s National Microbiology Laboratory show that Triosyn T-1000™ Series Respirators protect against Severe Acute Respiratory Syndrome (SARS).

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

New book predicts a "vaccine century"

A new book published by the Pan American Health Organization (PAHO) predicts that the 21st century will become the "century of vaccines" thanks to rapid developments in the field of immunization.

21 Jul 2004

Vaccination Week reached 40 Million in 35 countries

An estimated 40 million children and adults throughout the Western Hemisphere received vaccines during the first regionwide Vaccination Week in the Americas, held April 24-30 in 35 countries of the Americas.

21 Jul 2004

Russian scientists incorporate HIV antigen into a tomato

Russian scientists are currently creating a pleasant and harmless vaccine, and edible one at that. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center.

19 Jul 2004